Massive pulmonary embolism: review of management strategies with a focus on catheter-based techniques

References

• Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest121(3), 877–905 (2002).
   PubMed Web of Science ®Google Scholar
• Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation112(2), e28–e32 (2005).
   PubMed Web of Science ®Google Scholar
• Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation113(4), 577–582 (2006).
   PubMed Web of Science ®Google Scholar
• Torbicki A, Perrier A, Konstantinides S et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J.29(18), 2276–2315 (2008).
   PubMed Web of Science ®Google Scholar
• Kasper W, Konstantinides S, Geibel A et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J. Am. Coll. Cardiol30(5), 1165–1171 (1997).
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet353(9162), 1386–1389 (1999).
   PubMed Web of Science ®Google Scholar
• Tibbutt DA, Davies JA, Anderson JA et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism Br. Med. J.1, 343–347 (1974).
   PubMedGoogle Scholar
• Ly B, Arnesen H, Eie H, Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med. Scand.203(6), 465–470 (1978).
   PubMedGoogle Scholar
• Dotter CT, Seaman AJ, Rosch J et al. Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison. Vasc. Surg.13, 42–52 (1979).
   Google Scholar
• Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J. Thromb. Thrombolysis2(3), 227–229 (1995).
   PubMedGoogle Scholar
• The urokinase pulmonary embolism trial. A national cooperative study. Circulation47(Suppl. II), II-1 (1973).
   Google Scholar
• Marini C, Di Ricco G, Rossi G, Rindi M, Palla R, Giuntini C. Fibrinolytic effects of urokinase and heparin in acute pulmonary embolism: a randomized clinical trial. Respiration54(3), 162–173 (1988).
   PubMed Web of Science ®Google Scholar
• Dalla-Volta S, Palla A, Santolicandro A et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J. Am. Coll. Cardiol.20(3), 520–526 (1992).
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ, Haire WD, Feldstein ML et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet341(8844), 507–511 (1993).
   PubMed Web of Science ®Google Scholar
• Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N. Engl. J. Med.347(15), 1143–1150 (2002).
   PubMed Web of Science ®Google Scholar
• Levine M, Hirsh J, Weitz J et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest98(6), 1473–1479 (1990).
   PubMed Web of Science ®Google Scholar
• Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators. Chest97(3), 528–533 (1990).
   PubMed Web of Science ®Google Scholar
• Arcasoy SM, Kreit JW. Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest115(6), 1695–1707 (1999).
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ. Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue. Circulation104(24), 2876–2878 (2001).
   PubMed Web of Science ®Google Scholar
• Thabut G, Thabut D, Myers RP et al. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J. Am. Coll. Cardiol.40(9), 1660–1667 (2002).
   PubMed Web of Science ®Google Scholar
• Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation110(6), 744–749 (2004).
   PubMed Web of Science ®Google Scholar
• Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch. Intern. Med.162(22), 2537–2541 (2002).
   PubMed Web of Science ®Google Scholar
• Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest133(Suppl. 6), 454S–545S (2008).
   PubMed Web of Science ®Google Scholar
• Urokinase–streptokinase embolism trial. Phase 2 results. A cooperative study. JAMA229(12), 1606–1613 (1974).
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ, Agnelli G, Levine MN. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. Chest106(3), 718–724 (1994).
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ, Kessler CM, Heit J et al. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet2(8606), 293–298 (1988).
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ, Kessler CM, Heit JA et al. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J. Am. Coll. Cardiol.20(1), 24–30 (1992).
   PubMed Web of Science ®Google Scholar
• Meneveau N, Schiele F, Metz D et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. J. Am. Coll. Cardiol.31(5), 1057–1063 (1998).
   PubMed Web of Science ®Google Scholar
• Meneveau N, Schiele F, Vuillemenot A et al. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur. Heart J.18(7), 1141–1148 (1997).
   PubMed Web of Science ®Google Scholar
• Meyer G, Sors H, Charbonnier B et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J. Am. Coll. Cardiol.19(2), 239–245 (1992).
   PubMed Web of Science ®Google Scholar
• Sors H, Pacouret G, Azarian R, Meyer G, Charbonnier B, Simonneau G. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest106(3), 712–717 (1994).
   PubMed Web of Science ®Google Scholar
• Verstraete M, Miller GA, Bounameaux H et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation77(2), 353–360 (1988).
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schunemann HJ. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest133(Suppl. 6), 123S–131S (2008).
   PubMed Web of Science ®Google Scholar
• Aklog L, Williams CS, Byrne JG, Goldhaber SZ. Acute pulmonary embolectomy: a contemporary approach. Circulation105(12), 1416–1419 (2002).
   PubMed Web of Science ®Google Scholar
• Doerge HC, Schoendube FA, Loeser H, Walter M, Messmer BJ. Pulmonary embolectomy: review of a 15-year experience and role in the age of thrombolytic therapy. Eur. J. Cardiothorac. Surg.10(11), 952–957 (1996).
   PubMed Web of Science ®Google Scholar
• Meneveau N, Seronde MF, Blonde MC et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest129(4), 1043–1050 (2006).
   PubMed Web of Science ®Google Scholar
• Stein PD, Alnas M, Beemath A, Patel NR. Outcome of pulmonary embolectomy. Am. J. Cardiol.99(3), 421–423 (2007).
   PubMed Web of Science ®Google Scholar
• Suarez JA, Meyerrose GE, Phisitkul S et al. Review of catheter thrombectomy devices. Cardiology102(1), 11–15 (2004).
   PubMed Web of Science ®Google Scholar
• Kucher N. Catheter embolectomy for acute pulmonary embolism. Chest132(2), 657–663 (2007).
   PubMed Web of Science ®Google Scholar
• Uflacker R. Interventional therapy for pulmonary embolism. J. Vasc. Interv. Radiol.12(2), 147–164 (2001).
   PubMed Web of Science ®Google Scholar
• Schmitz-Rode T, Janssens U, Schild HH, Basche S, Hanrath P, Gunther RW. Fragmentation of massive pulmonary embolism using a pigtail rotation catheter. Chest114(5), 1427–1436 (1998).
   PubMed Web of Science ®Google Scholar
• Schmitz-Rode T, Janssens U, Duda SH, Erley CM, Gunther RW. Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter. J. Am. Coll. Cardiol.36(2), 375–380 (2000).
   PubMed Web of Science ®Google Scholar
• Tajima H, Murata S, Kumazaki T et al. Hybrid treatment of acute massive pulmonary thromboembolism: mechanical fragmentation with a modified rotating pigtail catheter, local fibrinolytic therapy, and clot aspiration followed by systemic fibrinolytic therapy. AJR Am. J. Roentgenol.183(3), 589–595 (2004).
   PubMed Web of Science ®Google Scholar
• Barbosa MA, Oliveira DC, Barbosa AT et al. Treatment of massive pulmonary embolism by percutaneous fragmentation of the thrombus. Arq. Bras. Cardiol.88(3), 279–284 (2007).
   PubMed Web of Science ®Google Scholar
• De Gregorio MA, Gimeno MJ, Mainar A et al. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J. Vasc. Interv. Radiol.13(2 Pt 1), 163–169 (2002).
   PubMed Web of Science ®Google Scholar
• Pieri S, Agresti P. Hybrid treatment with angiographic catheter in massive pulmonary embolism: mechanical fragmentation and fibrinolysis. Radiol. Med.112(6), 837–849 (2007).
   PubMed Web of Science ®Google Scholar
• Spies C, Khandelwal A, Smith TH, Jolly N, Kavinsky CJ. Percutaneous mechanical thrombectomy for massive pulmonary embolism using a conservative treatment strategy. J. Interv. Cardiol.21(6), 566–571 (2008).
   PubMed Web of Science ®Google Scholar
• Chauhan MS, Kawamura A. Percutaneous rheolytic thrombectomy for large pulmonary embolism: a promising treatment option. Catheter. Cardiovasc. Interv.70(1), 121–128 (2007).
   PubMed Web of Science ®Google Scholar
• Margheri M, Vittori G, Vecchio S et al. Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism. Am. J. Cardiol.101(2), 252–258 (2008).
   PubMed Web of Science ®Google Scholar
• Biederer J, Schoene A, Reuter M, Heller M, Muller-Hulsbeck S. Suspected pulmonary artery disruption after transvenous pulmonary embolectomy using a hydrodynamic thrombectomy device: clinical case and experimental study on porcine lung explants. J. Endovasc. Ther.10(1), 99–110 (2003).
   PubMed Web of Science ®Google Scholar
• Voigtlander T, Rupprecht HJ, Nowak B et al. Clinical application of a new rheolytic thrombectomy catheter system for massive pulmonary embolism. Catheter Cardiovasc. Interv.47(1), 91–96 (1999).
   PubMed Web of Science ®Google Scholar
• Sur JP, Garg RK, Jolly N. Rheolytic percutaneous thrombectomy for acute pulmonary embolism in a pediatric patient. Catheter. Cardiovasc. Interv.70(3), 450–453 (2007).
   PubMed Web of Science ®Google Scholar
• Brahmbhatt T, Tutton S, Mannebach P, Cinquegrani M. Rheolytic thrombectomy in patient with massive pulmonary embolism: a case report and review of literature. Catheter. Cardiovasc. Interv.70(6), 802–806 (2007).
   PubMed Web of Science ®Google Scholar
• Myat A, Ahsan A. Percutaneous mechanical thrombectomy for the treatment of acute massive pulmonary embolism: case report. Thromb. J.5(1), 20 (2007).
   PubMedGoogle Scholar
• Chiam P, Kwok V, Johan BA, Chan C. Major pulmonary embolism treated with a rheolytic thrombectomy catheter. Singapore Med. J.46(9), 479–482 (2005).
   PubMedGoogle Scholar
• Speciale G, Pelliccia F, Vitalone V, Segneri M, Valentini P, Richichi G. A case of massive pulmonary embolism treated with AngioJet thrombectomy system. Ital. Heart J. Suppl.6(5), 302–305 (2005).
   PubMedGoogle Scholar
• Feldman JP, Feinstein JA, Lamberti JJ, Perry SB. AngioJet catheter-based thrombectomy in a neonate with postoperative pulmonary embolism. Catheter. Cardiovasc. Interv.66(3), 442–445 (2005).
   PubMed Web of Science ®Google Scholar
• Brenes JC, Ferreira A, Galindo A. A pulmonary embolism treated with the AngioJet technique in a patient with double outlet right ventricle. J. Invasive Cardiol.16(1), 42–44 (2004).
   PubMedGoogle Scholar
• Dwarka D, Schwartz SA, Smyth SH, O’Brien MJ. Bradyarrhythmias during use of the AngioJet system. J. Vasc. Interv. Radiol.17(10), 1693–1695 (2006).
   PubMed Web of Science ®Google Scholar
• Blaustein HS, Schur I, Shapiro JM. Acute massive pulmonary embolism in a Jehovah’s witness: successful treatment with catheter thrombectomy. Chest117(2), 594–597 (2000).
   PubMed Web of Science ®Google Scholar
• Koning R, Cribier A, Gerber L et al. A new treatment for severe pulmonary embolism: percutaneous rheolytic thrombectomy. Circulation96(8), 2498–2500 (1997).
   PubMedGoogle Scholar
• Zeni PT Jr, Blank BG, Peeler DW. Use of rheolytic thrombectomy in treatment of acute massive pulmonary embolism. J. Vasc. Interv. Radiol.14(12), 1511–1515 (2003).
   PubMed Web of Science ®Google Scholar
• Iskander A, Nayak A, Chauhan MS. Submassive pulmonary embolism and paradoxical embolic stroke treated with percutaneous rheolytic thrombectomy and closure of the patent foramen ovale. Catheter. Cardiovasc. Interv.64(3), 356–360 (2005).
   PubMed Web of Science ®Google Scholar
• Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Zabakis P, Hahalis G. AngioJet rheolytic thrombectomy versus local intrapulmonary thrombolysis in massive pulmonary embolism: a retrospective data analysis. J. Endovasc. Ther.12(2), 206–214 (2005).
   PubMed Web of Science ®Google Scholar
• Vincent RN, Dinkins J, Dobbs MC. Mechanical thrombectomy using the AngioJect in a child with congenital heart disease. Catheter. Cardiovasc. Interv.61(2), 253–255 (2004).
   PubMed Web of Science ®Google Scholar
• Garg RK, Jolly N. Percutaneous thrombectomy for pulmonary embolism. J. Invasive Cardiol.18(12), 640 (2006).
   PubMedGoogle Scholar
• Skaf E, Beemath A, Siddiqui T, Janjua M, Patel NR, Stein PD. Catheter-tip embolectomy in the management of acute massive pulmonary embolism. Am. J. Cardiol.99(3), 415–420 (2007).
   PubMed Web of Science ®Google Scholar
• Margheri M, Falai M, Vittori G et al. Safety and efficacy of the AngioJet in patients with acute myocardial infarction: results from the Florence Appraisal Study of Rheolytic Thrombectomy (FAST). J. Invasive Cardiol.18(10), 481–486 (2006).
   PubMedGoogle Scholar
• Vecchio S, Vittori G, Chechi T et al. Percutaneous rheolytic thrombectomy with AngioJet for pulmonary embolism: methods and results in the experience of a high-volume center. G. Ital. Cardiol. (Rome)9(5), 355–363 (2008).
   PubMedGoogle Scholar
• Kuo WT, Gould MK, Louie JD, Rosenberg JK, Sze DY, Hofmann LV. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J. Vasc. Interv. Radiol.20(11), 1431–1440 (2009).
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ. Percutaneous mechanical thrombectomy for acute pulmonary embolism: a double-edged sword. Chest132(2), 363–365 (2007).
   PubMed Web of Science ®Google Scholar